Table of Contents China Oncology Biosimilars Market Research Report 2018 1 Oncology Biosimilars Overview 1.1 Product Overview and Scope of Oncology Biosimilars 1.2 Classification of Oncology Biosimilars by Product Category 1.2.1 China Oncology Biosimilars Sales (MT) Comparison by Type (2013-2025) 1.2.2 China Oncology Biosimilars Sales (MT) Market Share by Type in 2017 1.2.3 G-CSF 1.2.4 Hematopoietic Agents 1.2.5 Monoclonal Antibodies 1.3 China Oncology Biosimilars Market by Application/End Users 1.3.1 China Oncology Biosimilars Sales (MT) and Market Share Comparison by Applications (2013-2025) 1.3.2 Retail Pharmacies 1.3.3 Hospital Pharmacies 1.3.4 Online Pharmacies 1.4 China Oncology Biosimilars Market by Region 1.4.1 China Oncology Biosimilars Market Size (Million USD) Comparison by Region (2013-2025) 1.4.2 South China Oncology Biosimilars Status and Prospect (2013-2025) 1.4.3 East China Oncology Biosimilars Status and Prospect (2013-2025) 1.4.4 Southwest China Oncology Biosimilars Status and Prospect (2013-2025) 1.4.5 Northeast China Oncology Biosimilars Status and Prospect (2013-2025) 1.4.6 North China Oncology Biosimilars Status and Prospect (2013-2025) 1.4.7 Central China Oncology Biosimilars Status and Prospect (2013-2025) 1.5 China Market Size (Sales and Revenue) of Oncology Biosimilars (2013-2025) 1.5.1 China Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2025) 1.5.2 China Oncology Biosimilars Revenue (Million USD) and Growth Rate (%)(2013-2025) 2 China Oncology Biosimilars Market Competition by Players/Manufacturers 2.1 China Oncology Biosimilars Sales and Market Share of Key Players/Manufacturers (2013-2018) 2.2 China Oncology Biosimilars Revenue and Share by Players/Manufacturers (2013-2018) 2.3 China Oncology Biosimilars Average Price (USD/Kg) by Players/Manufacturers (2013-2018) 2.4 China Oncology Biosimilars Market Competitive Situation and Trends 2.4.1 China Oncology Biosimilars Market Concentration Rate 2.4.2 China Oncology Biosimilars Market Share of Top 3 and Top 5 Players/Manufacturers 2.4.3 Mergers & Acquisitions, Expansion in China Market 2.5 China Players/Manufacturers Oncology Biosimilars Manufacturing Base Distribution, Sales Area, Product Types 3 China Oncology Biosimilars Sales and Revenue by Region (2013-2018) 3.1 China Oncology Biosimilars Sales (MT) and Market Share by Region (2013-2018) 3.2 China Oncology Biosimilars Revenue (Million USD) and Market Share by Region (2013-2018) 3.3 China Oncology Biosimilars Price (USD/Kg) by Regions (2013-2018) 4 China Oncology Biosimilars Sales and Revenue by Type/ Product Category (2013-2018) 4.1 China Oncology Biosimilars Sales (MT) and Market Share by Type/ Product Category (2013-2018) 4.2 China Oncology Biosimilars Revenue (Million USD) and Market Share by Type (2013-2018) 4.3 China Oncology Biosimilars Price (USD/Kg) by Type (2013-2018) 4.4 China Oncology Biosimilars Sales Growth Rate (%) by Type (2013-2018) 5 China Oncology Biosimilars Sales by Application (2013-2018) 5.1 China Oncology Biosimilars Sales (MT) and Market Share by Application (2013-2018) 5.2 China Oncology Biosimilars Sales Growth Rate (%) by Application (2013-2018) 5.3 Market Drivers and Opportunities 6 China Oncology Biosimilars Players/Suppliers Profiles and Sales Data 6.1 Celltrion Inc. 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Oncology Biosimilars Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Celltrion Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) 6.1.4 Main Business/Business Overview 6.2 Pfizer Inc. 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 Oncology Biosimilars Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Pfizer Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) 6.2.4 Main Business/Business Overview 6.3 Biocon 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 Oncology Biosimilars Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Biocon Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) 6.3.4 Main Business/Business Overview 6.4 BIOCAD 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 Oncology Biosimilars Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 BIOCAD Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) 6.4.4 Main Business/Business Overview 6.5 Apotex Inc. 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 Oncology Biosimilars Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Apotex Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) 6.5.4 Main Business/Business Overview 6.6 Dr. Reddy’s Laboratories Ltd. 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Oncology Biosimilars Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) 6.6.4 Main Business/Business Overview 6.7 Sandoz International GmbH 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 Oncology Biosimilars Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Sandoz International GmbH Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) 6.7.4 Main Business/Business Overview 6.8 Intas Pharmaceuticals Ltd. 6.8.1 Company Basic Information, Manufacturing Base and Competitors 6.8.2 Oncology Biosimilars Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) 6.8.4 Main Business/Business Overview 6.9 STADA Arzneimittel AG 6.9.1 Company Basic Information, Manufacturing Base and Competitors 6.9.2 Oncology Biosimilars Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 STADA Arzneimittel AG Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) 6.9.4 Main Business/Business Overview 6.10 Teva Pharmaceutical Industries Ltd. 6.10.1 Company Basic Information, Manufacturing Base and Competitors 6.10.2 Oncology Biosimilars Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) 6.10.4 Main Business/Business Overview 7 Oncology Biosimilars Manufacturing Cost Analysis 7.1 Oncology Biosimilars Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Oncology Biosimilars 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Oncology Biosimilars Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 China Oncology Biosimilars Market Size (Sales and Revenue) Forecast (2018-2025) 11.1 China Oncology Biosimilars Sales (MT), Revenue (Million USD) Forecast (2018-2025) 11.2 China Oncology Biosimilars Sales (MT) Forecast by Type (2018-2025) 11.3 China Oncology Biosimilars Sales (MT) Forecast by Application (2018-2025) 11.4 China Oncology Biosimilars Sales (MT) Forecast by Region (2018-2025) 12 Research Findings and Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables and Figures Figure Global and China Market Size (Million USD) Comparison (2013-2025) Table Oncology Biosimilars Sales (MT) and Revenue (Million USD) Market Split by Product Type Table Oncology Biosimilars Sales (MT) by Application (2013-2025) Figure Product Picture of Oncology Biosimilars Table China Oncology Biosimilars Sales (MT) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025) Figure China Oncology Biosimilars Sales Volume Market Share by Types in 2017 Figure G-CSF Product Picture Figure Hematopoietic Agents Product Picture Figure Monoclonal Antibodies Product Picture Figure China Oncology Biosimilars Sales (MT) Comparison by Application (2013-2025) Figure China Sales Market Share (%) of Oncology Biosimilars by Application in 2017 Figure Retail Pharmacies Examples Table Key Downstream Customer in Retail Pharmacies Figure Hospital Pharmacies Examples Table Key Downstream Customer in Hospital Pharmacies Figure Online Pharmacies Examples Table Key Downstream Customer in Online Pharmacies Figure South China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025) Figure East China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025) Figure Southwest China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025) Figure Northeast China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025) Figure North China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025) Figure Central China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025) Figure China Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2025) Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate (%)(2013-2025) Table China Oncology Biosimilars Sales of Key Players/Manufacturers (2013-2018) Table China Oncology Biosimilars Sales Share (%) by Players/Manufacturers (2013-2018) Figure 2017 China Oncology Biosimilars Sales Share (%) by Players/Manufacturers Figure 2017 China Oncology Biosimilars Sales Share (%) by Players/Manufacturers Table China Oncology Biosimilars Revenue by Players/Manufacturers (2013-2018) Table China Oncology Biosimilars Revenue Market Share (%) by Players/Manufacturers (2013-2018) Figure 2017 China Oncology Biosimilars Revenue Market Share (%) by Players/Manufacturers Figure 2017 China Oncology Biosimilars Revenue Market Share (%) by Players/Manufacturers Table China Market Oncology Biosimilars Average Price of Key Players/Manufacturers (2013-2018) Figure China Market Oncology Biosimilars Average Price of Key Players/Manufacturers in 2017 Figure China Oncology Biosimilars Market Share of Top 3 Players/Manufacturers Figure China Oncology Biosimilars Market Share of Top 5 Players/Manufacturers Table China Players/Manufacturers Oncology Biosimilars Manufacturing Base Distribution and Sales Area Table China Players/Manufacturers Oncology Biosimilars Product Category Table China Oncology Biosimilars Sales (MT) by Regions (2013-2018) Table China Oncology Biosimilars Sales Share (%) by Regions (2013-2018) Figure China Oncology Biosimilars Sales Share (%) by Regions (2013-2018) Figure China Oncology Biosimilars Sales Market Share (%) by Regions in 2017 Table China Oncology Biosimilars Revenue (Million USD) and Market Share by Regions (2013-2018) Table China Oncology Biosimilars Revenue Market Share (%) by Regions (2013-2018) Figure China Oncology Biosimilars Revenue Market Share (%) by Regions (2013-2018) Figure China Oncology Biosimilars Revenue Market Share (%) by Regions in 2017 Table China Oncology Biosimilars Price (USD/Kg) by Regions (2013-2018) Table China Oncology Biosimilars Sales (MT) by Type (2013-2018) Table China Oncology Biosimilars Sales Share (%) by Type (2013-2018) Figure China Oncology Biosimilars Sales Share (%) by Type (2013-2018) Figure China Oncology Biosimilars Sales Market Share (%) by Type in 2017 Table China Oncology Biosimilars Revenue (Million USD) and Market Share by Type (2013-2018) Table China Oncology Biosimilars Revenue Market Share (%) by Type (2013-2018) Figure Revenue Market Share of Oncology Biosimilars by Type (2013-2018) Figure Revenue Market Share of Oncology Biosimilars by Type in 2017 Table China Oncology Biosimilars Price (USD/Kg) by Types (2013-2018) Figure China Oncology Biosimilars Sales Growth Rate (%) by Type (2013-2018) Table China Oncology Biosimilars Sales (MT) by Applications (2013-2018) Table China Oncology Biosimilars Sales Market Share (%) by Applications (2013-2018) Figure China Oncology Biosimilars Sales Market Share (%) by Application (2013-2018) Figure China Oncology Biosimilars Sales Market Share (%) by Application in 2017 Table China Oncology Biosimilars Sales Growth Rate (%) by Application (2013-2018) Figure China Oncology Biosimilars Sales Growth Rate (%) by Application (2013-2018) Table Celltrion Inc. Oncology Biosimilars Basic Information List Table Celltrion Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) Figure Celltrion Inc. Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018) Figure Celltrion Inc. Oncology Biosimilars Sales Market Share (%) in China (2013-2018) Figure Celltrion Inc. Oncology Biosimilars Revenue Market Share (%) in China (2013-2018) Table Pfizer Inc. Oncology Biosimilars Basic Information List Table Pfizer Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) Figure Pfizer Inc. Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018) Figure Pfizer Inc. Oncology Biosimilars Sales Market Share (%) in China (2013-2018) Figure Pfizer Inc. Oncology Biosimilars Revenue Market Share (%) in China (2013-2018) Table Biocon Oncology Biosimilars Basic Information List Table Biocon Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) Figure Biocon Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018) Figure Biocon Oncology Biosimilars Sales Market Share (%) in China (2013-2018) Figure Biocon Oncology Biosimilars Revenue Market Share (%) in China (2013-2018) Table BIOCAD Oncology Biosimilars Basic Information List Table BIOCAD Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) Figure BIOCAD Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018) Figure BIOCAD Oncology Biosimilars Sales Market Share (%) in China (2013-2018) Figure BIOCAD Oncology Biosimilars Revenue Market Share (%) in China (2013-2018) Table Apotex Inc. Oncology Biosimilars Basic Information List Table Apotex Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) Figure Apotex Inc. Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018) Figure Apotex Inc. Oncology Biosimilars Sales Market Share (%) in China (2013-2018) Figure Apotex Inc. Oncology Biosimilars Revenue Market Share (%) in China (2013-2018) Table Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Basic Information List Table Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) Figure Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018) Figure Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Sales Market Share (%) in China (2013-2018) Figure Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Revenue Market Share (%) in China (2013-2018) Table Sandoz International GmbH Oncology Biosimilars Basic Information List Table Sandoz International GmbH Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) Figure Sandoz International GmbH Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018) Figure Sandoz International GmbH Oncology Biosimilars Sales Market Share (%) in China (2013-2018) Figure Sandoz International GmbH Oncology Biosimilars Revenue Market Share (%) in China (2013-2018) Table Intas Pharmaceuticals Ltd. Oncology Biosimilars Basic Information List Table Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018) Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales Market Share (%) in China (2013-2018) Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Revenue Market Share (%) in China (2013-2018) Table STADA Arzneimittel AG Oncology Biosimilars Basic Information List Table STADA Arzneimittel AG Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) Figure STADA Arzneimittel AG Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018) Figure STADA Arzneimittel AG Oncology Biosimilars Sales Market Share (%) in China (2013-2018) Figure STADA Arzneimittel AG Oncology Biosimilars Revenue Market Share (%) in China (2013-2018) Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Basic Information List Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2013-2018) Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales (MT) and Growth Rate (%)(2013-2018) Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales Market Share (%) in China (2013-2018) Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Revenue Market Share (%) in China (2013-2018) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Oncology Biosimilars Figure Manufacturing Process Analysis of Oncology Biosimilars Figure Oncology Biosimilars Industrial Chain Analysis Table Raw Materials Sources of Oncology Biosimilars Major Players/Manufacturers in 2017 Table Major Buyers of Oncology Biosimilars Table Distributors/Traders List Figure China Oncology Biosimilars Sales (MT) and Growth Rate (%) Forecast (2018-2025) Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure China Oncology Biosimilars Price (USD/Kg) Trend Forecast (2018-2025) Table China Oncology Biosimilars Sales (MT) Forecast by Type (2018-2025) Figure China Oncology Biosimilars Sales (MT) Forecast by Type (2018-2025) Figure China Oncology Biosimilars Sales Volume Market Share Forecast by Type in 2025 Table China Oncology Biosimilars Sales (MT) Forecast by Application (2018-2025) Figure China Oncology Biosimilars Sales Volume Market Share Forecast by Application (2018-2025) Figure China Oncology Biosimilars Sales Volume Market Share Forecast by Application in 2025 Table China Oncology Biosimilars Sales (MT) Forecast by Regions (2018-2025) Table China Oncology Biosimilars Sales Volume Share Forecast by Regions (2018-2025) Figure China Oncology Biosimilars Sales Volume Share Forecast by Regions (2018-2025) Figure China Oncology Biosimilars Sales Volume Share Forecast by Regions in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources